(19)
(11) EP 0 544 671 A1

(12)

(43) Date of publication:
09.06.1993 Bulletin 1993/23

(21) Application number: 91907661.0

(22) Date of filing: 03.04.1991
(51) International Patent Classification (IPC): 
A61K 9/ 20( . )
A61K 47/ 48( . )
C08F 20/ 26( . )
C08F 20/ 42( . )
C08F 26/ 10( . )
C08F 212/ 12( . )
C08F 218/ 08( . )
C08F 220/ 06( . )
C08F 220/ 36( . )
C08F 220/ 58( . )
C08F 222/ 06( . )
C08F 246/ 00( . )
C08L 33/ 00( . )
A61K 47/ 32( . )
C08F 20/ 02( . )
C08F 20/ 34( . )
C08F 20/ 52( . )
C08F 212/ 00( . )
C08F 218/ 02( . )
C08F 220/ 04( . )
C08F 220/ 28( . )
C08F 220/ 46( . )
C08F 220/ 60( . )
C08F 226/ 10( . )
C08L 31/ 04( . )
C08L 33/ 04( . )
(86) International application number:
PCT/US1991/002319
(87) International publication number:
WO 1991/016057 (31.10.1991 Gazette 1991/25)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IT LI LU NL SE

(30) Priority: 18.04.1990 US 19900513267

(71) Applicant: THE UNIVERSITY OF UTAH
Salt Lake City, Utah 84112 (US)

(72) Inventors:
  • KOPECEK, Jindrich
    Salt Lake City, UT 84102 (US)
  • KIM, Sung, Wan
    Salt Lake City, UT 84117 (US)
  • BRONDSTED, Helle
    Salt Lake City, UT 84103 (US)
  • KOPECKOVA, Pavla
    Salt Lake City, UT 84102 (US)

(74) Representative: Goldin, Douglas Michael, et al 
J.A. KEMP & CO. 14, South Square Gray's Inn
London WC1R 5LX
London WC1R 5LX (GB)

   


(54) COLONIC-TARGETED ORAL DRUG-DOSAGE FORMS BASED ON CROSSLINKED HYDROGELS CONTAINING AZOBONDS AND EXHIBITING pH-DEPENDENT SWELLING